Language
Open app

Bristol Myers Squibb Co. stock outperforms competitors on strong trading day

Shares of Bristol Myers Squibb Co. (BMY) rose 1.25% to $64.63 on a Monday when the broader market saw declines, with the S&P 500 Index and Dow Jones Industrial Average both falling. The stock's performance outpaced its competitors despite the overall market downturn. Bristol Myers Squibb Co. closed 5.10% below its 52-week high.

Why it matters

Attributed market update with source link for portfolio context.

Sources

Attributed news only. Not investment advice.

Bristol Myers Squibb Co. stock outperforms competitors on strong trading day | TahmVest News · TahmVest